COMMENTARY - SHOULD IDIOSYNCRASY BE DEFINED AS EQUIVALENT TO TYPE-B ADVERSE DRUG-REACTIONS

Authors
RAWLINS MD
Citation
Md. Rawlins, COMMENTARY - SHOULD IDIOSYNCRASY BE DEFINED AS EQUIVALENT TO TYPE-B ADVERSE DRUG-REACTIONS, Pharmacoepidemiology and drug safety, 6(4), 1997, pp. 291-291
Citations number
3
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
Pharmacoepidemiology and drug safety → ACNP
ISSN journal
10538569
Volume
6
Issue
4
Year of publication
1997
Pages
291 - 291
Database
ISI
SICI code
1053-8569(1997)6:4<291:C-SIBD>2.0.ZU;2-M